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ARTICLE OPEN
Barriers to the provision of smoking cessation assistance:
a qualitative study among Romanian family physicians
Catalina Panaitescu1, Mandy A Moffat2, Siân Williams3, Hilary Pinnock4, Melinda Boros5, Cristian Sever Oana1, Sandra Alexiu1 and
Ioanna Tsiligianni6,7
BACKGROUND: Smoking cessation is the most effective intervention to prevent and slow down the progression of several
respiratory and other diseases and improve patient outcomes. Romania has legislation and a national tobacco control programme
in line with the World Health Organization Framework for Tobacco Control. However, few smokers are advised to quit by their
family physicians (FPs).
AIM: To identify and explore the perceived barriers that prevent Romanian FPs from engaging in smoking cessation with patients.
METHODS: A qualitative study was undertaken. A total of 41 FPs were recruited purposively from Bucharest and rural areas within
600 km of the city. Ten FPs took part in a focus group and 31 participated in semistructured interviews. Analysis was descriptive,
inductive and themed, according to the barriers experienced.
RESULTS: Five main barriers were identiﬁed: limited perceived role for FPs; lack of time during consultations; past experience and
presence of disincentives; patients’ inability to afford medication; and lack of training in smoking cessation skills. Overarching these
speciﬁc barriers were key themes of a medical and societal hierarchy, which undermined the FP role, stretched resources and
constrained care.
CONCLUSIONS: Many of the barriers described by the Romanian FPs reﬂected universally recognised challenges to the provision of
smoking cessation advice. The context of a relatively hierarchical health-care system and limitations of time and resources
exacerbated many of the problems and created new barriers that will need to be addressed if Romania is to achieve the aims of its
National Programme Against Tobacco Consumption.
npj Primary Care Respiratory Medicine (2014) 24, 14022; doi:10.1038/npjpcrm.2014.22; published online 10 July 2014
INTRODUCTION
The overall prevalence rate of smoking among the Romanian
population aged over 15 years is approximately 27%, with a higher
prevalence among men.1 According to the World Health
Organization (WHO), 77% of all deaths in Romania in 2008 were
caused by diseases for which tobacco smoking is the main risk
factor.1 Smoking cessation prevents and slows down the
progression of major diseases such as cardiovascular and
respiratory disease, cancer and diabetes.2,3 Family physicians
(FPs) are uniquely placed to intervene with patients who use
tobacco and support cessation.4 However, studies show that
smokers who visit their primary care physician for reasons other
than smoking are rarely offered assistance to quit or even the
minimum intervention of ‘brief advice’.5,6
Until recently, smoking cessation support services were not
available in Romania. In 2005, after the WHO Framework
Convention was ratiﬁed, speciﬁc legislation began to be adopted.
In 2007, the Ministry of Health initiated the National Programme
Against Tobacco Consumption, which included the Stop Smoking
support programme. This offered free training to any doctor
interested in providing smoking cessation support for their
patients and ﬁnancial incentives to become part of a national
network of centres where smokers could be offered free
counselling and medication.7 However, few FPs engaged with,
or referred patients to, the programme: e.g., the main author (CP)
was the only FP (from a total of 11,000 physicians in Romania)
involved in the programme over a 2-year period. The reasons why
FPs did not utilise this programme are unclear.
Several studies describe the professional behaviour of
Romanian FPs towards smokers and highlight the lack of
engagement in smoking cessation activities. In one study, more
than 70% of FPs knew about smoking cessation, but less than half
applied this knowledge in their own practices.8 Interventions
tended to be limited to brief advice for patients with a diagnosed
concomitant chronic disease,9 and few FPs referred patients to
smoking cessation specialists.8 None of the studies explain why
Romanian FPs ﬁnd it difﬁcult to engage in smoking cessation with
patients and provide support services for them.
This study aimed to identify and explore the perceived barriers
that prevent Romanian FPs from engaging in smoking cessation
with patients. Once these reasons are understood, speciﬁc
interventions can be developed to help FPs provide these services.
MATERIALS AND METHODS
A qualitative study was undertaken during 2011–2012. Written, informed
consent was obtained from all participants. As the study evaluated the
professional use of a service, and did not involve patients or the use of
patient data, it did not require ethical approval by any of the Romanian
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ethical committees. We used the complementary methods of focus groups
in which participant interactions facilitate expression and development of
ideas and help identify cultural norms,10 and subsequent individual
semistructured interviews in which speciﬁc topics raised by the groups can
be explored in depth.11
Change to the original protocol
To facilitate FPs’ participation and funding of venues in this very low-
budget project, we originally planned four focus groups sponsored by a
pharmaceutical company. However, in the ﬁrst group, a pulmonologist
who had spoken at a preceding promotional meeting attended and
actively participated in the discussion, which signiﬁcantly appeared to
inﬂuence/inhibit the FP participants’ expressed opinions. Despite the
ﬁnancial implications, we therefore decided to concentrate on (unfunded)
interviews rather than arrange further (sponsored) focus groups.
Participants
A purposive sampling strategy was used to recruit experienced, licensed
FPs to represent a diversity of urban (Bucharest) or rural (Ilfov, Iasi and
Bihor counties) or practice arrangements (solo/group, deprivation status),
personal characteristics (gender, age) and perspectives on smoking
cessation services. In addition to this maximum variation approach we
also sought FPs with diverse attitudes to smoking cessation (speciﬁcally
including outliers), or used snowballing techniques to identify people with
relevant roles or deemed to have particular perspectives.12
Participants for the sponsored focus group were identiﬁed and
approached by the pharmaceutical company representatives who were
asked to include FPs with different age/gender proﬁles and from diverse
demographic practices. The interviewees were identiﬁed and invited
verbally by CP through local networks, and during conferences and
professional meetings, with ‘snowballing’ to extend recruitment to others
potentially able to contribute a range of perspectives. Note was made of
the practice arrangements (solo/group) and demography (urban/rural) to
support purposive sampling. We continued to recruit until we reached data
saturation: i.e., until the interviews presented no new ideas or perspectives
related to the aim of our study (to explore the perceived barriers that
prevent Romanian FPs from engaging in smoking cessation with
patients).13
Data collection
The focus group and interviews were based around a topic guide
(Supplementary Appendix 1). Open-ended questions aimed to identify FPs’
perceptions (e.g., importance of smoking as a health problem), attitudes
(e.g., Is smoking cessation an essential task for primary care?), behaviours
(e.g., How do you normally deal with smokers in your practice?) and their
individual experiences, opinions, knowledge and willingness to use
smoking cessation options.
The focus group, facilitated by CP and MB (female FP (CP) and
psychologist (MB)), lasted for 45min and was audio-taped and transcribed
verbatim. Interviews (conducted by CP) lasted for 20–30min and were
conducted face-to-face or by telephone (to enable participation of
professionals working in rural areas). Budgetary restrictions precluded
the purchase of recording equipment and full transcription of interviews,
but comprehensive notes, taken by CP during and immediately after the
interviews, provided a contemporaneous record. This included some
verbatim quotes, as well as representative words and phrases, which were
then typed out for analysis.
Data analysis
Data were stored as Word documents (Microsoft, Redmond Washington)
and analysed manually by CP using highlighter pens, summaries and Word
tables. The limited budget precluded the use of qualitative data software.
Thematic analysis was used to explore key areas of interest, such as
perceived barriers and attitudes to providing or referring smokers to
smoking cessation support14 (see Supplementary Appendix 2 for the
coding structure). We speciﬁcally looked for novel or unexpected insights
and actively sought deviant cases.15 Responses from FPs in both rural and
urban areas were compared to look for different experiences among
participants. Analysis was carried out in Romanian with quotations
translated for dissemination (original quotations are available on request
from the author). The researchers (CP, MAM, CSO and SA) frequently
discussed the emergent ﬁndings. Preliminary themes were presented
at meetings with colleagues, and the discussion enabled emerging
ﬁndings to be interpreted, iterative changes to topic guides agreed, and
overarching themes to be identiﬁed and formulated.
RESULTS
Forty-one licensed FPs (4 male; 32 between the ages of 45 and 60
years) were recruited to the study. With one exception, all the FPs
were self-employed and worked in solo practices—the most
common professional arrangement in Romanian primary care.
One FP worked in a private medical centre. Ten FPs participated in
a focus group and 31 took part in semistructured interviews, seven
of whom were interviewed by telephone.
Overview of ﬁndings
Five barriers to provision of smoking cessation advice in family
practice were identiﬁed:
● Limited perceived role for FPs
● Lack of time during patient consultations
● Past experience and presence of disincentives
● Patients’ inability to afford medication
● FPs’ lack of training in smoking cessation skills
Limited perceived role of FPs
All FPs reported seeing patients daily in their ofﬁces who smoked.
However, FPs perceived themselves to have a minor role in
discussing cessation with patients. The strong sense of a medical
hierarchy underpinned a perception that the FP’s role should be to
refer patients to specialists (e.g., pulmonologists or psychologists)
rather than be fully involved in supporting cessation. If they were
to engage in smoking cessation with patients, FPs said they would
prefer to do this as part of a team and be supported in their
practice by specialists, especially pulmonologists. The pulmonol-
ogist was not only perceived as ‘being trained’ and thus having
the expertise to provide smoking cessation support, but their
advice was considered to carry more weight.
It is different when a pulmonologist tells you that you have
COPD and therefore you have to quit...
(FP 3, focus group)
Some FPs highlighted that psychiatrists were perceived as
being reluctant to engage in smoking cessation with their
psychiatric patients and, by example, this was seen as discoura-
ging FP involvement in smoking cessation.
Smoking cessation was recognised as important by the majority
of FPs and was typically described as ‘a disease’ and ‘a public
health problem’. In contrast, an FP who was an ex-smoker and
who had quit without external help believed stopping smoking to
be a ‘question of personal will power’ (FP 10, focus group) and did
not perceive a role for the FP or any other doctor in inﬂuencing a
patient’s motivation to quit. Similarly, another FP stated:
Smokers who really want to quit don’t need any help; those
who look for it [help with smoking cessation] are not
convinced.
(FP 5, focus group)
Most FPs believed their role was to offer brief advice, usually to
smokers with smoking-related pathologies, rather than to ‘healthy’
asymptomatic smokers:
You should not smoke, especially with your heart condition.
(FP 27, interview)
Smoking cessation assistance
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When asked how they thought they should be involved in
reducing the number of patients who smoked, many participants
said they thought they could be more ‘persuasive’ or ‘forceful’ in
highlighting the harm caused by smoking.
Most participants considered smoking cessation important not
just for the individual smoker but also for society. Some FPs
suggested that more support should be available from the
government or community—e.g., public campaigns, special
programmes supported from a ‘tax on vice’ and free quit phone
lines. The majority of FPs interviewed had heard about the Stop
Smoking programme, mainly from the media. However, none had
sought further information for their clinical practice.
Lack of time during patient consultations
All participants reported a lack of time as the main barrier to
supporting smoking cessation:
Sometimes I have the impression that the patient would like to
stay for a prolonged discussion on that subject [smoking
cessation], but I always feel ‘haunted’ by those in the waiting
room. So I usually ask the patient to make another appoint-
ment for this problem which, I must admit, seldom happens.
(FP 27, interview)
Another identiﬁed reason for time pressure was the complexity
of consultations in family medicine, which often have to address
more than one health problem, accompanied by increased
paperwork, described by most participants as ‘overwhelming’.
Past experience and presence of disincentives
A lack of motivation to engage in smoking cessation with patients
was found to stem mainly from concern about the doctor–patient
relationship and also the lack of any ﬁnancial incentive to
participate in such work.
The doctor–patient relationship was seen to be at risk if the
patient was perceived to be uninterested in discussing smoking.
I have patients who smoke but visit me, for example, for a bout
of the common cold. When I ask if they still smoke, most
become defensive and irritated. It’s as if they would like to tell
me to treat their cold but keep out of their personal lives.
(FP 22, interview)
Some doctors admitted that they had, on occasion, made
concessions to patients to keep them ‘on the practice list’. If they
felt the patient had no interest or appeared uncomfortable when
their smoking habit was raised, the FP retreated from the subject
and avoided addressing it in future.
Another identiﬁed risk was that of jeopardising follow-up visits,
especially if the patient had started smoking again. One FP shared
an experience where engaging in smoking cessation had a
negative impact on care for the patient’s other issues:
I had a woman patient with diabetes and hypertension who
tried to stop smoking and who disappeared for several months.
She missed all appointments. When she ﬁnally reappeared, she
admitted she was too ashamed to tell me she couldn’t manage
to stop [smoking]. She had not been treated for her diabetes
and hypertension for some time. To tell you the truth, I prefer
to have her condition balanced and under control with the
other parameters even if she is still smoking!
(FP 7, focus group).
Finance was another factor that affected FPs’ motivation to
engage in smoking cessation with patients. All FPs reported that
speciﬁc payments for the service would be a highly motivating
factor (Romanian FPs have a low annual income. The budget of
the entire health-care system made up just 3.6% of the Gross
Domestic Product in 2011).16
An FP’s personal experience could have a powerful effect on
their motivation to engage in smoking cessation with patients.
One FP recounted at some length how a patient for whom they
had prescribed smoking cessation pharmacotherapy had
developed depression. According to the psychiatrist who treated
the patient, the depressive episode had been associated with the
administration of the smoking cessation drug. The FP said the
incident was the reason she would never initiate smoking
cessation therapy again.
Another FP told a dramatic narrative about her residency
training in a psychiatric hospital. One day she had found
herself in fear of physical assault by a violent patient. She
managed to calm him down by offering him a pack of
cigarettes; at the time, the hospital rules were that each patient
who smoked should be supplied with a cigarette ration ‘on the
house’. The FP believed the packet of cigarettes saved her life,
and from then on decided not to intervene in this aspect of her
patients’ lives.
Patients’ inability to afford medication
Barriers from the patients’ perspectives were also identiﬁed by
FPs. Many highlighted the cost of pharmacotherapy as a barrier.
The Stop Smoking programme only offered free counselling and
medication to those smokers enrolled in it, but was beset by
accessibility and recurrent ﬁnancial problems. FPs said they felt
‘frustrated’ and ‘helpless’ when treatment was delayed or
abandoned because of cost. Cost was considered to be a key
reason why patients relapsed during a cessation attempt:
The trust that the patient has in me and in himself or herself is
seriously altered and I often think twice before I start all over
again, even if the patient is willing to try again.
(FP 16, interview)
Participants often used their own personal observations and
judgements of the patients’ socio-economic status to decide
whether the treatment was affordable rather than directly asking
the patient.
Some doctors also mentioned the geographical barriers:
e.g., rural pharmacies did not always stock smoking cessation
aids.
FPs’ lack of training in smoking cessation skills
During the focus group and interviews, questions that explored
the FPs’ professional knowledge received a variety of responses.
The need for additional training was universally acknowledged.
The general lack of education about smoking cessation during
undergraduate and postgraduate training was highlighted, as well
speciﬁc uncertainties about pharmacotherapy.
They [courses] would be welcome because neither during the
university nor later, nobody teaches us.
(FP 11, interview)
You know, all this tobacco related stuff is relatively new (...) so,
as long as people are interested in quitting, yes, training is
welcome.
(FP 31, interview)
I have heard, of course, about nicotine gum, varenicline and
electronic cigarettes, but I am not very sure which should be
prescribed to whom.
(FP 8, focus group)
Smoking cessation assistance
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Many participants agreed that they felt unprepared, especially
when they had to assist patients who had relapsed. One FP
expressed their frustration and uncertainty about how to help ‘the
type of patient, who has tried everything? No matter what you say
to the smoker, he has already tried and decided it will not work’.
(FP 2, focus group).
DISCUSSION
Main ﬁndings
To our knowledge, this is the only study exploring the perceived
barriers that prevent Romanian FPs from engaging in smoking
cessation with patients. Our ﬁndings are consistent with previous
international studies that report FPs’ lack of time and training in
smoking cessation skills as barriers. Romanian FPs do not perceive
the provision of smoking cessation services to be part of their
work and therefore limit their advice to patients with smoking-
related conditions. FPs’ past experience, patients’ ability to afford
medication and the presence of disincentives were important
barriers. Although not unique to Romania, the barriers identiﬁed
appear to be exacerbated by a relatively hierarchical and under-
ﬁnanced health-care system.
Strengths and limitations of this study
Our qualitative methodology allowed us to explore the percep-
tions, opinions and personal experiences of the participants. Our
purposive sampling enabled recruitment of participants from
various regions of the country and different demographic areas
(urban and rural). We recognise that we may not have accessed all
possible opinions (for example, although the preponderance of
female participants is broadly representative of the gender
balance of Romanian FPs, young FPs were under-represented in
the study). However, we achieved data saturation with respect to
our aim of identifying and exploring perceptions about barriers to
engaging in smoking cessation.
This was a low-budget project that accepted pharmaceutical
company sponsorship to fund invitations and a suitable venue for
the focus group as a strategy to encourage more FPs to attend.
However, after concerns that the data may have been inﬂuenced
during the sponsored focus group meeting, a decision was taken
to collect further data by individual interviews conducted face-to-
face, or by telephone17 to reduce travel costs. Although the
potential bias in the data from the sponsored focus group is a
limitation, the undue inﬂuence of the pulmonologist contributed
to our understanding of the inﬂuence of hierarchical structures
in the Romanian health-care system. We have systematically
identiﬁed quotes from the focus group to enable appropriate
interpretation.
An important limitation is that we did not have the resources to
audio-record and transcribe the interviews as we had intended to
do with four sponsored focus groups. However, detailed notes
were taken by CP during and immediately after the interviews so
that relevant data were recorded and could be referred to during
the process of coding and analysis. Although this reduced the
number of verbatim quotations available for analysis, it should not
have affected our overall understanding of the content of the
interview.
Interpretation of ﬁndings in relation to previously published work
Our study found that medical support for smoking cessation is
hampered at primary care level by common barriers,18–23 which, in
the context of the Romanian health-care system, acquired some
speciﬁc aspects. Two overarching themes that encumbered each
of the identiﬁed barriers were (i) hierarchy, and (ii) time and
resources.
(i) Hierarchy. The Romanian health-care system is a hierarchical
one and this manifests at different levels:
FPs’ relationship with other specialists: FPs appeared to under-
estimate their role in smoking cessation provision, thinking that
they should refer a patient to a specialist rather than take
responsibility themselves. This lack of conﬁdence and sense of
inferiority compared with secondary care has been found in
primary care studies in other countries.24–26 The FP who believed a
psychiatrist blamed her for causing a bout of depression reﬂects
this issue. The FPs who preferred support from specialists,
especially pulmonologists, as part of a team involved in smoking
cessation services could be another subtle reﬂection of the
same issue.
FPs’ relationship with patients: In Romania a signiﬁcant hierarchy
exists between the doctor and the patient. This was mirrored in
some of the language used by FPs—e.g., ‘You should not smoke’,
‘…too ashamed to tell me she couldn’t manage to stop
[smoking]’.
There is an additional factor that inﬂuences the FPs’ decision on
whether or not to approach smoking cessation. In Romania,
payment for primary care is based 80% per capita and 20% fee-
for-service. (Since April 2013, this has been changed to 70 and
30%, respectively.) This means that the number of patients on an
FP’s ‘list’ is directly related to income so that some of our
participants said they were reluctant to bring up the topic of
smoking cessation with an uninterested patient for fear of losing
them from their list.
FPs’ relationship with policy makers: FPs’ relationship with policy
makers is another way the hierarchical theme manifests and may
explain the limited input and lack of initiative shown by FPs in the
study. Several FPs expected public campaigns or special
programmes to be organised by the government. When asked
how FPs could advertise smoking cessation for patients, there
were no suggestions, not even the provision of an ‘information
only’ approach—e.g., posters or leaﬂets in the waiting room with
support service telephone numbers.27,28
The lack of reimbursement might also give Romanian FPs a
negative perception on the policy direction and the importance
that is given to their contribution to the smoking cessation
assistance.
(ii) Time and resources. A lack of time and shortage of resources
are common complaints in primary care,29,30 made more difﬁcult
by the complexity of consultations in family medicine.31,32 In the
context of Romanian family practice, this is exacerbated by
speciﬁc practical issues: lack of affordable administrative staff,
overload of administrative and ﬁscal data collection to be
recorded for every patient on each consultation and the
redundancy of documents that must be submitted to different
health-care institutions.
The way in which appointments are scheduled, without the aid
of a receptionist, patients’ expectations of ‘walk in’ appointments
and the fact that family medicine ofﬁces are usually shared with
other FPs (two shifts per ofﬁce) limit the ﬂexibility for lengthening
patient consultations.
Participants working in rural areas appeared to have more
scheduling problems than those in urban areas, particularly FPs
serving scattered populations whose patients’ visits to the ofﬁce
are often dependent on public transportation schedules (e.g., on
occasion, many patients arrived at the FP’s ofﬁce at the same time).
The problem of patients who cannot afford prescriptions is not
unique,33–35 but the economic circumstances in Romania make
the problem worse. (The Stop Smoking programme only offered
free counselling and medication to those smokers enrolled in it.)
In Romania, there is no health insurance cover for cessation drug
Smoking cessation assistance
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therapy, and hence purchasing pharmacotherapy is an outlay that
some smokers ﬁnd difﬁcult. The market price is considered too
high compared with the average personal income of the
population, especially in rural areas. For example, a loaf of bread
costs 0.50 Euros compared with 6–7 Euros for nicotine gum (30
pieces of 2 or 4 mg), 14 Euros for nicotine patches (16 pieces), 35
Euros for bupropion (60 tablets) and 37 Euros for varenicline (28
tablets). The average price of one pack of cigarettes in Romania is
about 3 Euros (and even cheaper on the black market). It is
cheaper to smoke than it is to buy smoking cessation drugs.
Implications for practice, future research and policy
This study shows that FPs are aware they are an important ‘access
point’ to smoking cessation counselling for patients even if they
underestimate the importance of their role. FPs said they saw
smokers ‘every day’ in their ofﬁce, suggesting that they pay
attention to the smoking status of their patients, even if they do
not engage them in discussion about cessation. Most participants
knew about the pharmacological options of smoking cessation
drug therapy on the Romanian market. These ﬁndings could be
useful when designing future training programmes, which, as well
as covering basic clinical knowledge, should focus on strategies to
overcome the identiﬁed barriers.
For instance, to overcome the barrier of hierarchy in the
relationship with other specialists, FPs’ training needs to include
discussions about their role—and possibly conﬁdence building
and assertiveness training…
Improving motivational interviewing skills that help determine
patients’ willingness to quit, and responding with appropriately
matched smoking cessation approaches, would enable FPs to
successfully deal with potentially frustrating and demotivating
situations (for both doctor and patient) and avoid ‘abandoned
cases’. It could also lay the foundations for a more evidence-based
approach to patients—e.g., relying more on guidelines and less on
previous negative personal experiences.
Locally tailored guidelines may also be needed to ﬁt the speciﬁc
health-care context, focusing on brief advice36 as a practical approach
to patients who smoke in typical primary care consultations.
Teaching evidence-based management strategies such as
ﬂagging smokers’ medical ﬁles37 or, more ambitiously, devising
better scheduling systems could also prove useful in order to
accommodate patients on a walk-in basis and yet still have
available time to offer stop smoking counselling.
Despite the progress achieved in many departments of the
health-care system, Romania continues to have one of the highest
standardised death rates from non-communicable diseases, many
of which have smoking-related causes.38 With only a fraction of
the public health-care spending of other EU countries16 and
resources channelled mainly to secondary care and curative
programmes, the Romanian health-care system needs to consider
its priorities.39,40 A strengthened primary care system could be the
key to improved access, quality and efﬁciency of public health-
care services—e.g., by improving stop smoking rates. Continuity of
support, training and conﬁdence building, as well as a better
allocation of resources, is needed; otherwise future programmes
will face the same fate as the previous Stop Smoking programme,
now ended by a lack of ﬁnancial resources.
Conclusions
Many of the barriers described by the Romanian FPs reﬂected
universally recognised challenges to the provision of smoking
cessation advice, such as lack of time, limited resources, fear of
endangering the doctor–patient relationship and lack of con-
ﬁdence in smoking cessation skills. The context of a middle
income economy, pressure on primary care facilities, and relatively
hierarchical health-care systems exacerbated many of these
problems and created barriers that will need to be addressed if
Romania is to achieve the aims of its National Programme Against
Tobacco Consumption.
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